跳至主要内容
临床试验/NCT02455102
NCT02455102已完成不适用

Electronic Warning System to Improve Stroke Prevention in Atrial Fibrillation - A Quality Improvement Initiative at the University Hospital Bern

Insel Gruppe AG, University Hospital Bern2 个研究点 分布在 1 个国家目标入组 1,707 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,707
试验地点
2
主要终点
Rate of initiation of adequate measures to prevent stroke (oral anticoagulant prescription) by physician in charge

研究概览

简要总结

The aim of this randomized controlled study is to evaluate whether a newly designed electronic warning system will increase the initiation rate of adequate stroke preventive measures in patients with atrial fibrillation.

详细描述

A large proportion of patients with atrial fibrillation do not receive stroke prevention therapy in line with the guidelines, in spite of the presence of an increased risk of stroke. It will be investigated whether an electronic alert to physicians, whose patients with atrial fibrillation do not receive stroke preventive measures, will increase the rate of adequate stroke preventive measures as compared to a control group of patients without an electronic alert. The electronic alerts will be sent if patients with atrial fibrillation but without adequate stroke preventive measures receive in-patient treatment at the University Hospital Bern. The electronic alert system includes a feature that helps the physicians in charge to evaluate the CHA2DS2VASC Score. At the end of the hospital stay medical discharge letters will be reviewed for initiation of adequate stroke preventive measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All in-patients with atrial fibrillation

排除标准

  • Ongoing anticoagulant therapy

结局指标

主要结局

Rate of initiation of adequate measures to prevent stroke (oral anticoagulant prescription) by physician in charge

时间窗: End of hospital stay (expected average duration of 1 week)

Reviewed from discharge letter

次要结局

  • Use of the CHA2DS2VASc score calculation tool by the physician in charge(During hospital stay (expected average duration of 1 week))
  • Rate of correct evaluation of the CHA2DS2VASC Score through the calculation tool by physician in charge(End of hospital stay (expected average duration of 1 week))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验